Effects of zoledronic acid on bone mineral density in premenopausal women receiving neoadjuvant or adjuvant therapies for HR+ breast cancer: the ProBONE II study
Year: 2014
Type: article
Study designs: Randomized Controlled Trial, Clinical Trial
Source: Osteoporosis International
Authors: P. Hadji, A. Kauka, M. Ziller, K. Birkholz, M. Baier, M. Muth, M. Bauer
Institutions: Philipps University of Marburg, Novartis (Germany)
Language: English
Topic: Bone health and treatments
Subfield: Oncology
Field: Medicine
Domain: Health Sciences
Open Access status: closed
OpenAlex ID: W1964337669